Purdue Pharmaceutical Products L.P - Articles and news items

Verastem licenses Duvelisib from Infinity Pharmaceuticals for $28 million

Industry news / 3 November 2016 / Niamh Louise Marriott, Digital Content Producer

Verastem licensed exclusive worldwide rights to develop and commercialise Infinity’s oncology product candidate duvelisib…

 

The deadline for submissions to the EPR Awards is 9 June 2017! Entry is FREE, so don't delay...
+